mRNA 疫苗的制剂和递送技术。
Formulation and Delivery Technologies for mRNA Vaccines.
机构信息
Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, 43210, Columbus, OH, USA.
Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH, 43210, USA.
出版信息
Curr Top Microbiol Immunol. 2022;440:71-110. doi: 10.1007/82_2020_217.
mRNA vaccines have become a versatile technology for the prevention of infectious diseases and the treatment of cancers. In the vaccination process, mRNA formulation and delivery strategies facilitate effective expression and presentation of antigens, and immune stimulation. mRNA vaccines have been delivered in various formats: encapsulation by delivery carriers, such as lipid nanoparticles, polymers, peptides, free mRNA in solution, and ex vivo through dendritic cells. Appropriate delivery materials and formulation methods often boost the vaccine efficacy which is also influenced by the selection of a proper administration route. Co-delivery of multiple mRNAs enables synergistic effects and further enhances immunity in some cases. In this chapter, we overview the recent progress and existing challenges in the formulation and delivery technologies of mRNA vaccines with perspectives for future development.
mRNA 疫苗已成为预防传染病和治疗癌症的多功能技术。在疫苗接种过程中,mRNA 制剂和传递策略有助于有效表达和呈现抗原,并进行免疫刺激。mRNA 疫苗已经以各种形式递送到体内:通过递药载体(如脂质纳米颗粒、聚合物、肽、游离 mRNA 溶液)进行包裹,或者通过树突细胞进行体外传递。合适的递药材料和制剂方法通常可提高疫苗的疗效,而疫苗的传递途径的选择也会影响其疗效。共递送多种 mRNA 可在某些情况下产生协同作用,进一步增强免疫效果。在本章中,我们从未来发展的角度综述了 mRNA 疫苗制剂和传递技术的最新进展和现存挑战。